Chemed(DE:CXM)
€496.00-2.00 (-0.40%)
DE:CXM
Chemed earnings date
€496.00
At close:-2.00 (-0.40%)
Chemed (CXM) Q2 2021 Earnings Report
2 Followers
DE:CXM Q2 2021 EPS Results
- Actual EPS
- EUR 4.18
- Consensus EPS
- EUR 3.90
- Beat/Miss
- Beat by +EUR 0.28
- One Year Ago EPS
- EUR 4.01
DE:CXM Q2 2021 Revenue Results
- Actual Revenue
- EUR 484.11M
- Expected Revenue
- EUR 465.55M
- Beat/Miss
- Beat by +EUR 18.56M
- YoY Revenue Growth
- +5.99%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/27/2021
- Time
- After Close
- Conference Call
- Tuesday, July 27, 2021
DE:CXM Upcoming Earnings
Chemed's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:CXM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 6.69- | 5.84 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 5.856.14 | 4.79 | 28.08% (+1.35) | |
| Jul 28, 2026 | 2026 (Q2) | 5.095.51 | 3.88 | 41.92% (+1.63) | |
| Apr 23, 2026 | 2026 (Q1) | 4.825.14 | 5.12 | 0.36% (+0.02) | |
| Feb 25, 2026 | 2025 (Q4) | 6.395.84 | 6.21 | -6.00% (-0.37) | |
| Oct 31, 2025 | 2025 (Q3) | 4.884.79 | 5.13 | -6.56% (-0.34) | |
| Jun 30, 2025 | 2025 (Q2) | 4.663.88 | 4.98 | -21.94% (-1.09) | |
| Apr 23, 2025 | 2025 (Q1) | 5.055.12 | 4.73 | 8.27% (+0.39) | |
| Feb 26, 2025 | 2024 (Q4) | 6.176.21 | 6 | 3.48% (+0.21) | |
| Oct 29, 2024 | 2024 (Q3) | 5.135.13 | 4.84 | 6.02% (+0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

